Apyx Medical (APYX) Gross Margin (2011 - 2026)
Apyx Medical's (APYX) quarterly Gross Margin came in at 63.89% in Q2 2026, up 161.0% on a YoY basis from 24.48% in Q2 2025, and up 0.69% quarter-over-quarter from 63.45% in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Gross Margin (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Gross Margin for 16 consecutive years, with 63.89% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 161.0% year-over-year to 63.89%; the trailing twelve-month figure through Jun 2026 stood at 63.5% (up 186.0% YoY), and the FY2025 full-year result was 62.53%, up 149.0% from the prior year.
- Gross Margin grew to 63.89% in Q2 2026 per APYX's latest filing, from 63.45% in the prior quarter.
- Across five years, Gross Margin topped out at 68.38% in Q2 2023 and bottomed at 58.07% in Q1 2024.
- Historically, Gross Margin has averaged 63.32% across 5 years, with a median of 63.1% in 2022.
- The sharpest annual moves came in 2022 and 2025: Gross Margin tumbled 688 bps in 2022, then surged 389 bps in 2025.
- Over 5 years, Gross Margin stood at 65.35% in 2022, then decreased by 7 bps to 60.9% in 2023, then rose by 3 bps to 63.03% in 2024, then declined by 1 bps to 62.61% in 2025, then climbed by 2 bps to 63.89% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 63.89%, 63.45%, and 62.61% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 45.84% |
| 10 | Apyx Medical | 125.85 Mn | 98.23 Mn | 8.87 Mn | 63.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.89% |
| Mar 31, 2026 | 63.45% |
| Dec 31, 2025 | 62.61% |
| Sep 30, 2025 | 64.43% |
| Jun 30, 2025 | 62.28% |
| Mar 31, 2025 | 60.07% |
| Dec 31, 2024 | 63.03% |
| Sep 30, 2024 | 60.54% |
| Jun 30, 2024 | 61.68% |
| Mar 31, 2024 | 58.07% |
| Dec 31, 2023 | 60.90% |
| Sep 30, 2023 | 66.62% |
| Jun 30, 2023 | 68.38% |
| Mar 31, 2023 | 62.37% |
| Dec 31, 2022 | 65.35% |
| Sep 30, 2022 | 63.17% |
| Jun 30, 2022 | 67.18% |
| Mar 31, 2022 | 65.79% |
| Dec 31, 2021 | 72.22% |
| Sep 30, 2021 | 68.09% |